RESEARCH-USE BIOSIMILAR ANTIBODY

Tenatumomab

Monoclonal antibody · IgG2b

TNCIgG2bRUO

Tenatumomab (ST2146) is a murine monoclonal antibody against tenascin-C. And tenascin-C, the large extracellular glycoprotein, is overexpressed in cancer. Tenatumomab has been used for Pretargeted Antibody Guided Radioimmunoresearch (PAGRIT), and delivering radionuclides to tumors via PAGRIT and direct 131Iodine labeling approach.

TARGETTNC
YMonoclonal antibody
CATALOGSC-BS-126
CATALOG NUMBERSC-BS-126
MOLECULAR WEIGHTApprox. 147.86 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tenatumomab (ST2146) is a murine monoclonal antibody against tenascin-C. And tenascin-C, the large extracellular glycoprotein, is overexpressed in cancer. Tenatumomab has been used for Pretargeted Antibody Guided Radioimmunoresearch (PAGRIT), and delivering radionuclides to tumors via PAGRIT and direct 131Iodine labeling approach.

Tenatumomab is a recombinant research-use antibody directed against TNC.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tenatumomab | StellaCyte